FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to compounds inhibiting HCV, stereoisomers, tautomers and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof and the use of a mixture of one or more of these compositions for the preparation of medicines for inhibiting the HCV.
.
EFFECT: said compounds can effectively inhibit the hepatitis C virus NS5A, and can be used for preparing medicines for preventing and treating diseases of HCV-NS5A infection.
7 cl, 2 tbl, 167 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POLYHETEROCYCLIC COMPOUNDS USED AS HIGHLY EFFECTIVE INHIBITORS OF HEPATITIS C VIRUS | 2011 |
|
RU2535664C2 |
| HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS | 2010 |
|
RU2546656C2 |
| ARGINASE INHIBITORS AND METHODS OF USE THEREOF | 2011 |
|
RU2695650C2 |
| TRICYCLIC CONDENSED DERIVATIVES OF PYRIDIN-2-ONE AND USE THEREOF AS BRD4 INHIBITORS | 2016 |
|
RU2734959C2 |
| DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | 2009 |
|
RU2514937C2 |
| METHODS FOR SYNTHESIS OF DIHYDROPYRIDOPHTHALAZINONE DERIVATIVES | 2011 |
|
RU2561732C2 |
| PD-L1 ANTAGONIST COMPOUND | 2020 |
|
RU2823231C1 |
| FURO[3,2-B]PYRAN DERIVATIVES, APPLICABLE IN SYNTHESIS OF ANALOGUES | 2011 |
|
RU2579511C2 |
| BENZOXAZINE-OXAZOLIDINONE COMPOUND DISPLACED BY A NITROGEN-CONTAINING HETEROCYCLE, METHOD OF SYNTHESIS AND APPLICATION THEREOF | 2018 |
|
RU2744784C1 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND USE THEREOF | 2014 |
|
RU2696585C2 |
